AI-powered immune profiling from histopathology slides for chemo-radiotherapy outcome prediction in rectal cancer: a study using clinical trial and real-world cohorts.

EBioMedicine · 2025 · PMC12790592 · PMID 41253645

Europe PMC DOI

hedged sentence

0.2272

closest p · 4.5× alpha

0.2272

boldest claim

The sentences

not as significantp = 0.2272not close (p > 0.1)

TAM +− patients also tended to have a higher density of mitotic figures, while not as significant (median difference = 6.96, 95% CI: 1.99–15.92, p = 0.2272).

also in 271 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.